Li Du
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting chemoattractant chemokine (C-C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders.
Journal: Frontiers in immunology
Published: January 14, 2023
Association between Helicobacter pylori infection and carotid atherosclerosis in Chinese adults.
Journal: Atherosclerosis plus
Published: April 16, 2021
Elevated chemokines and cytokines for eosinophils in neuromyelitis optica spectrum disorders.
Journal: Multiple sclerosis and related disorders
Published: February 28, 2021
Thymic Involution and Altered Naive CD4 T Cell Homeostasis in Neuromyelitis Optica Spectrum Disorder.
Journal: Frontiers in immunology
Published: December 22, 2020
Different roles of soluble CD40 ligand in central nervous system damage.
Journal: Neurological research
Published: March 18, 2020
Glucocorticoid receptor mutations and clinical sensitivity to glucocorticoid in Chinese multiple sclerosis patients.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: September 06, 2019
CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders.
Journal: BioMed research international
Published: July 05, 2018
Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
Journal: Neuroimmunomodulation
Published: May 17, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026